These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 31662004)

  • 1. Effect of anti-C5 antibody on recuperation from ischemia/reperfusion-induced acute kidney injury.
    Zilberman-Itskovich S; Abu-Hamad R; Stark M; Efrati S
    Ren Fail; 2019 Nov; 41(1):967-975. PubMed ID: 31662004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of complement factor C5 protects against renal ischemia-reperfusion injury: inhibition of late apoptosis and inflammation.
    De Vries B; Matthijsen RA; Wolfs TG; Van Bijnen AA; Heeringa P; Buurman WA
    Transplantation; 2003 Feb; 75(3):375-82. PubMed ID: 12589162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human mesenchymal stromal cells ameliorate complement induced inflammatory cascade and improve renal functions in a rat model of ischemia-reperfusion induced acute kidney injury.
    Zilberman-Itskovich S; Abu-Hamad R; Zarura R; Sova M; Hachmo Y; Stark M; Neuman S; Slavin S; Efrati S
    PLoS One; 2019; 14(9):e0222354. PubMed ID: 31513644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of captopril treatment on recuperation from ischemia/reperfusion-induced acute renal injury.
    Efrati S; Berman S; Hamad RA; Siman-Tov Y; Ilgiyaev E; Maslyakov I; Weissgarten J
    Nephrol Dial Transplant; 2012 Jan; 27(1):136-45. PubMed ID: 21680852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predominant role for C5b-9 in renal ischemia/reperfusion injury.
    Zhou W; Farrar CA; Abe K; Pratt JR; Marsh JE; Wang Y; Stahl GL; Sacks SH
    J Clin Invest; 2000 May; 105(10):1363-71. PubMed ID: 10811844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treprostinil, a prostacyclin analog, ameliorates renal ischemia-reperfusion injury: preclinical studies in a rat model of acute kidney injury.
    Ding M; Tolbert E; Birkenbach M; Akhlaghi F; Gohh R; Ghonem NS
    Nephrol Dial Transplant; 2021 Jan; 36(2):257-266. PubMed ID: 33156922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of complement C5 reduces local and remote organ injury after intestinal ischemia/reperfusion in the rat.
    Wada K; Montalto MC; Stahl GL
    Gastroenterology; 2001 Jan; 120(1):126-33. PubMed ID: 11208721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adipose-derived mesenchymal stem cells therapy for acute kidney injury induced by ischemia-reperfusion in a rat model.
    Zhang JB; Wang XQ; Lu GL; Huang HS; Xu SY
    Clin Exp Pharmacol Physiol; 2017 Dec; 44(12):1232-1240. PubMed ID: 28688148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term effect of the complement inhibitor eculizumab on kidney function in patients with paroxysmal nocturnal hemoglobinuria.
    Hillmen P; Elebute M; Kelly R; Urbano-Ispizua A; Hill A; Rother RP; Khursigara G; Fu CL; Omine M; Browne P; Rosse W
    Am J Hematol; 2010 Aug; 85(8):553-9. PubMed ID: 20658586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myocardial infarction and apoptosis after myocardial ischemia and reperfusion: role of the terminal complement components and inhibition by anti-C5 therapy.
    Vakeva AP; Agah A; Rollins SA; Matis LA; Li L; Stahl GL
    Circulation; 1998 Jun; 97(22):2259-67. PubMed ID: 9631876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complement 5 Inhibition Ameliorates Hepatic Ischemia/reperfusion Injury in Mice, Dominantly via the C5a-mediated Cascade.
    Kusakabe J; Hata K; Tamaki I; Tajima T; Miyauchi H; Wang Y; Nigmet Y; Okamura Y; Kubota T; Tanaka H; Tsuruyama T; Uemoto S
    Transplantation; 2020 Oct; 104(10):2065-2077. PubMed ID: 32384381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recovery of renal function after administration of adipose-tissue-derived stromal vascular fraction in rat model of acute kidney injury induced by ischemia/reperfusion injury.
    Lee C; Jang MJ; Kim BH; Park JY; You D; Jeong IG; Hong JH; Kim CS
    Cell Tissue Res; 2017 Jun; 368(3):603-613. PubMed ID: 28283911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving renal outcomes in chronic anemia: learning from paroxysmal nocturnal hemoglobinuria.
    Guasch A
    Am J Hematol; 2010 Aug; 85(8):551-2. PubMed ID: 20658585
    [No Abstract]   [Full Text] [Related]  

  • 14. Hypoxic mesenchymal stem cells ameliorate acute kidney ischemia-reperfusion injury via enhancing renal tubular autophagy.
    Tseng WC; Lee PY; Tsai MT; Chang FP; Chen NJ; Chien CT; Hung SC; Tarng DC
    Stem Cell Res Ther; 2021 Jun; 12(1):367. PubMed ID: 34183058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oat1/3 restoration protects against renal damage after ischemic AKI.
    Schneider R; Meusel M; Betz B; Held C; Möller-Ehrlich K; Büttner-Herold M; Wanner C; Gekle M; Sauvant C
    Am J Physiol Renal Physiol; 2015 Feb; 308(3):F198-208. PubMed ID: 25391897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apoptosis repressor with caspase recruitment domain deficiency accelerates ischemia/reperfusion (I/R)-induced acute kidney injury by suppressing inflammation and apoptosis: The role of AKT/mTOR signaling.
    Yingjie K; Haihong Y; Lingwei C; Sen Z; Yuanting D; Shasha C; Liutong P; Ying W; Min Z
    Biomed Pharmacother; 2019 Apr; 112():108681. PubMed ID: 30970510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Notch2/Hes-1 pathway plays an important role in renal ischemia and reperfusion injury-associated inflammation and apoptosis and the γ-secretase inhibitor DAPT has a nephroprotective effect.
    Huang R; Zhou Q; Veeraragoo P; Yu H; Xiao Z
    Ren Fail; 2011; 33(2):207-16. PubMed ID: 21332343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphodiesterase-5 inhibition attenuates early renal ischemia-reperfusion-induced acute kidney injury: assessment by quantitative measurement of urinary NGAL and KIM-1.
    Sohotnik R; Nativ O; Abbasi A; Awad H; Frajewicki V; Bishara B; Sukhotnik I; Armaly Z; Aronson D; Heyman SN; Nativ O; Abassi Z
    Am J Physiol Renal Physiol; 2013 Apr; 304(8):F1099-104. PubMed ID: 23364806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue-specific deletion of Crry from mouse proximal tubular epithelial cells increases susceptibility to renal ischemia-reperfusion injury.
    Miao J; Lesher AM; Miwa T; Sato S; Gullipalli D; Song WC
    Kidney Int; 2014 Oct; 86(4):726-37. PubMed ID: 24850152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement activation and effect of eculizumab in scleroderma renal crisis.
    Devresse A; Aydin S; Le Quintrec M; Demoulin N; Stordeur P; Lambert C; Gastoldi S; Pirson Y; Jadoul M; Morelle J
    Medicine (Baltimore); 2016 Jul; 95(30):e4459. PubMed ID: 27472742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.